Musso Alan A 4
4 · Fulcrum Therapeutics, Inc. · Filed Aug 9, 2023
Insider Transaction Report
Form 4
Musso Alan A
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-08-07+432,800→ 432,800 totalExercise: $4.01Exp: 2033-08-06→ Common Stock (432,800 underlying)
Footnotes (1)
- [F1]This option was granted on August 7, 2023 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of August 7, 2023. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.